- Filed
- Nov 6, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2024 · Nov 1, 2024 | 66.79M sh |
| Current Liabilities | Q3 2024 · Sep 30, 2024 | $30.17M |
| Current Liabilities | Q3 2024 · Dec 31, 2023 | $39.91M |
| Total Liabilities | Q3 2024 · Sep 30, 2024 | $144.34M |
| Total Liabilities | Q3 2024 · Dec 31, 2023 | $171.63M |
| Current Assets | Q3 2024 · Sep 30, 2024 | $191.25M |
| Current Assets | Q3 2024 · Dec 31, 2023 | $272.62M |
| Total Assets | Q3 2024 · Sep 30, 2024 | $248.78M |
| Total Assets | Q3 2024 · Dec 31, 2023 | $374.76M |
| Cash And Equivalents | Q3 2024 · Dec 31, 2023 | $66.45M |
| Shares Diluted restated | Q3 2024 · Sep 30, 2023 | 65.91M sh |
| Shares Diluted | Q3 2024 · Sep 30, 2023 | 63.95M sh |
| Capex | Q3 2024 · Sep 30, 2023 | $2.82M |
| Operating Cash Flow | Q3 2024 · Sep 30, 2023 | −$27.77M |
| Stockholders Equity | Q3 2024 · Sep 30, 2023 | $231.91M |
| Stockholders Equity | Q3 2024 · Jun 30, 2023 | $254.29M |
| Stockholders Equity | Q3 2024 · Dec 31, 2022 | $282.49M |
| Eps Diluted | Q3 2024 · Sep 30, 2023 | −$0.43 |
| Eps Diluted | Q3 2024 · Sep 30, 2023 | −$1.43 |
| Eps Basic | Q3 2024 · Sep 30, 2023 | −$0.43 |
| Eps Basic | Q3 2024 · Sep 30, 2023 | −$1.43 |
| Sga Expense | Q3 2024 · Sep 30, 2023 | $11.64M |
| Sga Expense | Q3 2024 · Sep 30, 2023 | $37.47M |
| Rd Expense | Q3 2024 · Sep 30, 2023 | $21.86M |
| Rd Expense | Q3 2024 · Sep 30, 2023 | $65.69M |
| Net Income | Q3 2024 · Sep 30, 2023 | −$28.27M |
| Net Income | Q3 2024 · Sep 30, 2023 | −$91.43M |
| Operating Income | Q3 2024 · Sep 30, 2023 | −$31.36M |
| Operating Income | Q3 2024 · Sep 30, 2023 | −$100.14M |
| Revenue | Q3 2024 · Sep 30, 2023 | $2.15M |
| Revenue | Q3 2024 · Sep 30, 2023 | $3.03M |